TGTX: 31% | TG Therapeutics shares are trading higher following a Q1 revenue beat and increased 2024 Briumvi US net product revenue outlook.
SBUX: -13% | Starbucks shares are trading lower following weaker-than-expected Q2 earnings.
PALI: 64% | Palisade Bio shares are trading higher after the company announced completion of its analysis to determine the effects of bioactivated PALI-2108 on TNF-α production in a whole blood assay.